UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

The New England journal of medicine, 2017-03, Vol.376 (13), p.1211-1222

2017

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

The New England journal of medicine, 2018-06, Vol.378 (23), p.2191-2201

2018

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty

Journal of bone and joint surgery. American volume, 2014-02, Vol.96 (4), p.272

2014

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban in Peripheral Artery Disease after Revascularization

The New England journal of medicine, 2020-05, Vol.382 (21), p.1994-2004

2020

Link zum Volltext

Verfügbarkeit prüfen

Complication Rates After Hip or Knee Arthroplasty in Morbidly Obese Patients

Clinical orthopaedics and related research, 2013-10, Vol.471 (10), p.3358-3366

2013

Link zum Volltext

Verfügbarkeit prüfen

Stroke Outcomes in the COMPASS Trial

Circulation (New York, N.Y.), 2019-02, Vol.139 (9), p.1134-1145

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2020-01, Vol.323 (2), p.130

2020

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies

Thrombosis and haemostasis, 2011-03, Vol.105 (3), p.444

2011

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

The Lancet. Haematology, 2020-01, Vol.7 (1), p.e18-e27

2020

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Drug Development

Journal of the American College of Cardiology, 2015-04, Vol.65 (15), p.1567-1582

2015

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

The Lancet (British edition), 2009-05, Vol.373 (9676), p.1673-1680

2009

Link zum Volltext

Verfügbarkeit prüfen

Planning for the future of population health: the Johns Hopkins Medicine experience

The American journal of managed care, 2023-07, Vol.29 (7), p.e189-e191

2023

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation

Journal of thrombosis and haemostasis, 2020-07, Vol.18 (7), p.1672-1685

2020

Link zum Volltext

Verfügbarkeit prüfen

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

The New England journal of medicine, 2010-12, Vol.363 (26), p.2499-2510

2010

Link zum Volltext

Verfügbarkeit prüfen

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

The New England journal of medicine, 2012-04, Vol.366 (14), p.1287-1297

2012

Link zum Volltext

Verfügbarkeit prüfen

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

The Lancet (British edition), 2015-06, Vol.385 (9985), p.2363-2370

2015

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Major Bleeding Events

Journal of the American College of Cardiology, 2014-03, Vol.63 (9), p.891-900

2014

Link zum Volltext

Verfügbarkeit prüfen

Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial

Stroke (1970), 2019-11, Vol.50 (11), p.3184-3190

2019

Link zum Volltext

Verfügbarkeit prüfen

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Thrombosis journal, 2013-09, Vol.11 (1), p.21-21

2013

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)

The American heart journal, 2018-05, Vol.199, p.83-91

2018

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban for Stroke Prevention in East Asian Patients From the ROCKET AF Trial

Stroke (1970), 2014-06, Vol.45 (6), p.1739-1747

2014

Link zum Volltext

Verfügbarkeit prüfen

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

European heart journal, 2015-02, Vol.36 (5), p.288-296

2015

Link zum Volltext

Verfügbarkeit prüfen

Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial

Stroke (1970), 2020-06, Vol.51 (6), p.1797-1804

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 430

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(362)
Mit Volltextzugriff
(391)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(428)
Japanisch
(32)
Deutsch
(1)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(247)
Life Sciences & Biomedicine
(240)
Humans
(188)
Cardiovascular System & Cardiology
(125)
Female
(116)
Male
(111)
Aged
(102)
Cardiac & Cardiovascular Systems
(93)
Middle Aged
(83)
Rivaroxaban
(79)
Biological And Medical Sciences
(65)
Medical Sciences
(63)
Treatment Outcome
(60)
Peripheral Vascular Disease
(56)
General & Internal Medicine
(45)
Medicine, General & Internal
(43)
Double-Blind Method
(42)
Stroke
(42)
Anticoagulants
(39)
Hemorrhage - Chemically Induced
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty

Rivaroxaban in Peripheral Artery Disease after Revascularization

Complication Rates After Hip or Knee Arthroplasty in Morbidly Obese Patients

Stroke Outcomes in the COMPASS Trial

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial

Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies

Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Cardiovascular Drug Development

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

Planning for the future of population health: the Johns Hopkins Medicine experience

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Factors Associated With Major Bleeding Events

Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)

Rivaroxaban for Stroke Prevention in East Asian Patients From the ROCKET AF Trial

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)

Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial

Suchergebnisse filtern